Literature DB >> 16923666

Characterizing the emerging population of prescription opioid abusers.

Stacey C Sigmon1.   

Abstract

Despite an alarming recent increase in prescription opioid abuse, the characteristics of prescription opioid abusers remain largely unknown. In this study, the demographic and drug use characteristics of 75 methadone patients (36 prescription opioid and 39 heroin users) were compared using a retrospective chart review. Prescription opioid abusers exhibited a profile of characteristics that may predict favorable treatment response, including less severe opioid use and IV drug use, and greater social stability compared to primary heroin abusers. Despite the limitations inherent in this retrospective chart review, this study provides initial evidence that prescription opioid abusers may have a number of characteristics that predict favorable treatment response. This new information may inform and assist current efforts to develop efficacious treatments for prescription opioid abuse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923666     DOI: 10.1080/10550490600625624

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  44 in total

1.  Prescription Drug Abuse & Diversion: Role of the Pain Clinic.

Authors:  Khary K Rigg; Samantha J March; James A Inciardi
Journal:  J Drug Issues       Date:  2010

2.  Comparing buprenorphine induction experience with heroin and prescription opioid users.

Authors:  Suzanne Nielsen; Maureen Hillhouse; Larissa Mooney; Jacqueline Fahey; Walter Ling
Journal:  J Subst Abuse Treat       Date:  2012-02-01

3.  Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; David A Fiellin; Marilyn Byrne; Hilary S Connery; William Dickinson; John Gardin; Margaret L Griffin; Marc N Gourevitch; Deborah L Haller; Albert L Hasson; Zhen Huang; Petra Jacobs; Andrzej S Kosinski; Robert Lindblad; Elinore F McCance-Katz; Scott E Provost; Jeffrey Selzer; Eugene C Somoza; Susan C Sonne; Walter Ling
Journal:  Arch Gen Psychiatry       Date:  2011-11-07

4.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Michael I Fingerhood; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

5.  Understanding the etiology of prescription opioid abuse: implications for prevention and treatment.

Authors:  Khary K Rigg; John W Murphy
Journal:  Qual Health Res       Date:  2013-05-08

6.  Grit in patients with substance use disorders.

Authors:  Margaret L Griffin; Katherine A McDermott; R Kathryn McHugh; Garrett M Fitzmaurice; Roger D Weiss
Journal:  Am J Addict       Date:  2016-10-19

7.  Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings.

Authors:  Sean M Murphy; Dana Dweik; Sterling McPherson; John M Roll
Journal:  Am J Drug Alcohol Abuse       Date:  2015-01       Impact factor: 3.829

8.  Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers.

Authors:  Andrew C Meyer; Mollie E Miller; Stacey C Sigmon
Journal:  Addict Behav       Date:  2014-11-18       Impact factor: 3.913

9.  HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users.

Authors:  Christina S Meade; Leah J McDonald; Roger D Weiss
Journal:  Am J Addict       Date:  2009 Jul-Aug

10.  Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy.

Authors:  Nancy M Petry; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.